This is a prospective, multicenter, blinded, randomized controlled clinical trial designed to evaluate the safety and efficacy of a single-use intravascular ultrasound ablation catheter and ultrasound ablation system in the treatment of primary hypertension.
Aged ≥18 years and ≤75 years, regardless of gender.
Documented history of primary hypertension.
Office systolic blood pressure (SBP) ≥150 mmHg and <180 mmHg;
Office diastolic blood pressure (DBP) ≥90 mmHg;
Unsuitable Renal Artery Anatomy for Treatment
Main renal artery diameter <4 mm or length <20 mm.
Accessory renal artery diameter ≥ 2 mm and <4 mm.
Renal artery stenosis >50% in the main renal artery.